NEW YORK, April 24, 2017 /PRNewswire/ --
According to data published by Arcview Market Research, retail sales taxes in state-sanctioned cannabis markets totaled more
than $500 million in 2016 in Colorado, Washington, and Oregon alone, and $836
million since adult-use sales began in 2014. Nearly 1.9 million North Americans are legally using cannabis to manage
conditions as severe as polymorphic seizures and as common as chronic pain. Millions more are consuming it legally in adult-use
states with little or no negative impact. The report also points out that illicit sales are now being rolled back at the fastest
rates and in those states with the most mature legal adult-use markets. Arcview forecasts growth will reaccelerate beginning in
2018, as adult-use sales ramp up in Canada, California, and
Massachusetts along with medical sales in Florida.
ChineseInvestors.com, Inc. (OTC: CIIX), General Cannabis Corp. (OTC: CANN), United Cannabis Corp. (OTC: CNAB), Cannabis Sativa,
Inc. (OTC: CBDS), Axim Biotechnologies, Inc. (OTC: AXIM)
The research indicates that the biggest political win for the legal cannabis industry in the U.S. election came in
California. California pioneered the modern cannabis policy
reform movement in 1996, when voters passed Proposition 215, which is the Compassionate Care Act. Though voters failed to approve
adult use in 2010, they voted overwhelmingly in 2016 to make adult use legal in a state that represents the world's sixth-largest
economy. Nevada also voted to legalize adult use, though a similar initiative failed narrowly in
Arizona.
ChineseInvestors.com, Inc. (OTCQB: CIIX) earlier today announced, 'An update on its financial and business achievements
for the third quarter of 2017, as well as its outlook for the remainder of the current fiscal year and 2018.'
Financial Highlights:
- Filed form 10Q with the U.S. Securities and Exchange Commission (SEC) reflecting significantly higher revenues for the
three- and nine-month periods ended February 28, 2017, as compared to the same periods of fiscal
2016. Operating revenues increased 95% and 109%, respectively. - Revenues from the investor relations business continued to grow
in the third quarter, accounting for approximately 60% of total revenues.
Business Highlights: - Completed a $5 million private placement with proceeds to be allocated
toward the development and branding of hemp-based health production line and retail sales operations; Shanghai & United States office expansions and infrastructure
development, among other things. - Officially established and registered CBD Biotechnology Co. Ltd. ('XiBiDi Biotechnology Co.
Ltd.'), a wholly-owned foreign entity of CIIX, in the Pudong Free-Trade Area in Shanghai. -
Officially launched Chinese language online store ChineseCBDoil.com operated by CBD Biotechnology Co. Ltd., offering hemp-based
health products to the Chinese community. - We have begun a private placement of a new series of our preferred stock offered only
to Canadian investors.
Looking forward, Wang states, "The blueprint of our Company's corporate business strategy has changed as we are entering the
legal hemp industry and because of this, our revenues this quarter did not exceed that of the previous quarter. However, revenues
for the nine-month period increased by more than 100%. We believe our plan to market and sell hemp-based health products in
the United States and China will generate substantial revenues
for CIIX in FY2018. Our overall goal in 2018 is for CIIX to achieve annual revenue growth rate of more than 100%, while cutting
costs and achieving profitability."
General Cannabis Corp. (OTCQB: CANN) is the comprehensive resource for the highest quality service providers available
to the regulated Cannabis Industry. We are a trusted partner to the cultivation, production and retail side of the cannabis
business. On March 27th the company announced in response to growing demand, that its security
division, Iron Protection Group (IPG), the premier provider of protection services for the regulated cannabis industry, will
begin offering its services in California. By opening an office in Sacramento, IPG will
serve the largest regulated cannabis market in the world, now that the state voted to legalize the recreational use of marijuana
for adults last November.
United Cannabis Corp. (OTCQB: CNAB) was formed to advance the use of cannabinoids in medicine through research, product
development and education. On January 12th announced that it has teamed with Jamaica-based Cannabis Research & Development and initiated a pilot program in collaboration with the
Rastafari Studies Centre for Cannabis Research, University of West Indies, Mona, to establish protocols for the development of
Ital Standards, which will be used as a guide for the processing, cultivation and consumption of cannabis. United Cannabis will
work in collaboration with the Rastafari Studies Centre to support the activities of the DHAPA Association in accord with their
broader objective of establishing an infrastructure for licensed Rastafari farmers and trainees to participate in the Jamaican
marijuana industry. The Joint Venture's initial task will be to document and verify the genetics of the Centre's preliminary
plantings, as well as provide guidance in the development of appropriate standards and training methods for future
activities.
Cannabis Sativa, Inc. (OTCQB: CBDS) on April 13 th announced that it has
entered into a license agreement for the manufacture, marketing and sale of the Company's White Rabbit products in the
State of California. The Company anticipates adding products to its California licensing agreement in the coming months. Moreover, the Company is seeking to engage additional
licensees in states where medical cannabis is legal. The Company announces that it closed its acquisition of the White Rabbit
brand of cannabis sprays and cannabis mints (http://www.enjoywhiterabbit.com). The acquisition includes the exclusive and proprietary product formulations,
product mixes, manufacturing methods and branding. The White Rabbit product line currently consists of fast acting low dose
cannabis oral sprays and popular low dose cannabis mints.
Axim Biotechnologies, Inc. (OTCQB: AXIM) On March 7 th reported on the
enrollment of 40 patients and commencement of its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS)
with the company's CanChew Plus® CBD gum. The study is being conducted by Renger Witkamp, Professor and Chair in Nutrition and
Pharmacology, at Wageningen University in the Netherlands. Selected from a pool of over 400
patients, 40 trial patients aged 18-65 will be subject to a randomized, double-blind, cross-over trial of 8 weeks. Patients will
receive a maximum 6 chewing gums per day, either containing 50 mg of cannabidiol per chewing gum in case of the CanChew chewing
gum, or a placebo chewing gum.
Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts
on Trending Financial News from all these companies. "The Latest Buzz in Financial News"
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
service agreements with the companies which are the subject to the articles posted on the Site or other editorials for
advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions as we purely incorporate public market research along with financial and corporate news.
FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media
platform. We also do not include any personal opinions or commentary. For this release, FinancialBuzz.com expects to be
compensated three thousand dollars for financial news dissemination and pr services by
chineseInvestors.com inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on
this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement
and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com has signed a two year agreement with
chineseinvestors.com inc. for one hundred thousand restricted common shares for continued financial news dissemination and pr
services. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR
advertising. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information
about any companies the information contained herein is not intended to be used as the basis for investment decisions and should
not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to
buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result
from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes
electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own
independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By
accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended
from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase,
hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor.
This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular
security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and
tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions.
We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to
change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not
guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com
For further information:
Media Contact: info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com